Knight Therapeutics (GUD) Stock Chart & Stock Price History C$6.13 -0.01 (-0.16%) As of 07/11/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Knight Therapeutics Stock Price Performance The Knight Therapeutics (GUD) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 7.17%, with a year-to-date return of 14.79%. In the past month, the stock has increased 1.66%, reflecting recent market activity. As of the latest close, Knight Therapeutics traded at C$6.13 with a market cap of C$620.05 million and volume of 8,939 shares. Five years ago, the stock traded at C$6.99, representing a 12.30% decrease over that period. At the time, it had a market cap of C$920.60 million and a volume of 180,361 shares. Receive GUD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.82%1 Month Performance+1.66%3 Month Performance+9.66%Year-To-Date Performance+14.79%1 Year Performance+7.17%5 Year Performance-12.30% GUD Stock Chart for Sunday, July, 13, 2025 GUD Chart by TradingView Knight Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025C$6.14C$6.13-0.16%C$6.16C$6.048,939 shsC$620.05 million07/10/2025C$6.10C$6.14+0.66%C$6.18C$6.0931,227 shsC$621.06 million07/09/2025C$6.08C$6.10+0.33%C$6.11C$6.0527,456 shsC$617.02 million07/08/2025C$6.04C$6.08+0.66%C$6.14C$6.0059,741 shsC$614.99 million07/07/2025C$6.05C$6.04-0.17%C$6.06C$6.0036,446 shsC$610.95 million07/04/2025C$6.02C$6.05+0.50%C$6.06C$6.019,509 shsC$611.96 million07/03/2025C$6.00C$6.02+0.33%C$6.05C$5.97121,652 shsC$608.92 million07/02/2025C$5.83C$6.00+2.92%C$6.02C$5.8150,813 shsC$606.90 million07/01/2025C$5.83C$5.83C$5.87C$5.7519,898 shsC$589.71 million06/30/2025C$5.75C$5.83+1.39%C$5.87C$5.7519,898 shsC$589.71 million Get the Latest News and Ratings for GUD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025C$5.75C$5.75C$5.77C$5.75117,529 shsC$581.61 million06/26/2025C$5.76C$5.75-0.17%C$5.83C$5.7372,968 shsC$581.61 million06/25/2025C$5.80C$5.76-0.69%C$5.81C$5.7633,813 shsC$582.62 million06/24/2025C$5.81C$5.80-0.17%C$5.85C$5.7531,753 shsC$586.67 million06/23/2025C$5.85C$5.81-0.68%C$5.91C$5.818,767 shsC$587.68 million06/20/2025C$5.84C$5.85+0.17%C$5.95C$5.8226,608 shsC$591.73 million06/19/2025C$5.94C$5.84-1.68%C$6.01C$5.8418,569 shsC$590.72 million06/18/2025C$6.07C$5.94-2.14%C$6.17C$5.9426,789 shsC$600.83 million06/17/2025C$6.02C$6.07+0.83%C$6.16C$6.02951,769 shsC$613.98 million06/16/2025C$6.03C$6.02-0.17%C$6.08C$6.0118,608 shsC$608.92 million06/13/2025C$6.09C$6.03-0.99%C$6.06C$5.9741,423 shsC$609.94 million06/12/2025C$6.00C$6.09+1.50%C$6.10C$6.0046,921 shsC$616.00 million Related Companies CRON Stock Price Chart TLRY Stock Price Chart ACB Stock Price Chart WEED Stock Price Chart OGI Stock Price Chart CPH Stock Price Chart CRDL Stock Price Chart RX Stock Price Chart HLS Stock Price Chart SUGR Stock Price Chart Receive GUD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:GUD) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Knight Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Knight Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
